Anne F. Luetkemeyer

Infectious Disease

995 Potrero Ave
San Francisco, CA 94110

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 100 publications

MEASURING DOXYPEP USE RELATIVE TO STI RATES AT A SAN FRANCISCO STI CLINIC REVEALS RACIAL INEQUITIES IN DISEASE PREVENTION IMPACT.

MEASURING DOXYPEP USE RELATIVE TO STI RATES AT A SAN FRANCISCO STI CLINIC REVEALS RACIAL INEQUITIES IN DISEASE PREVENTION IMPACT.

Journal: Sexually transmitted diseases

Published: June 22, 2026

Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts.

Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts.

Journal: The New England journal of medicine

Published: May 13, 2026

Tecovirimat for the Treatment of Mpox.

Tecovirimat for the Treatment of Mpox.

Journal: The New England journal of medicine

Published: February 25, 2026

Hepatitis B virus vaccination in people with HIV: what's new?

Hepatitis B virus vaccination in people with HIV: what's new?

Journal: Current opinion in HIV and AIDS

Published: December 07, 2025

The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances.

The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances.

Journal: Vaccine

Published: October 31, 2025

Performance Evaluation of the Xpert® HCV Test on Fingerstick Blood in a Prospective Observational Clinical Study at CLIA-Waived Sites in the United States.

Performance Evaluation of the Xpert® HCV Test on Fingerstick Blood in a Prospective Observational Clinical Study at CLIA-Waived Sites in the United States.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: August 20, 2025

Doxy-PEP could select for ceftriaxone resistance in Neisseria gonorrhoeae - Authors' reply.

Doxy-PEP could select for ceftriaxone resistance in Neisseria gonorrhoeae - Authors' reply.

Journal: The Lancet. Infectious diseases

Published: April 04, 2025

"It's Been a Very Liberating Experience": Doxycycline Postexposure Prophylaxis for Sexually Transmitted Infection Prevention and Experiences With Sexual Pleasure by Men Who Have Sex With Men.

"It's Been a Very Liberating Experience": Doxycycline Postexposure Prophylaxis for Sexually Transmitted Infection Prevention and Experiences With Sexual Pleasure by Men Who Have Sex With Men.

Journal: Sexually transmitted diseases

Published: April 01, 2025

Short Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-C.

Short Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-C.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: March 26, 2025

Pharmacogenetics of plasma dolutegravir exposure during 1-month rifapentine/isoniazid treatment of latent tuberculosis.

Pharmacogenetics of plasma dolutegravir exposure during 1-month rifapentine/isoniazid treatment of latent tuberculosis.

Journal: Pharmacogenetics and genomics

Published: February 17, 2025

Doxycycline Postexposure Prophylaxis and Sexually Transmitted Infection Trends.

Doxycycline Postexposure Prophylaxis and Sexually Transmitted Infection Trends.

Journal: JAMA internal medicine

Published: January 06, 2025

Doxycycline to prevent bacterial sexually transmitted infections in the USA: final results from the DoxyPEP multicentre, open-label, randomised controlled trial and open-label extension.

Doxycycline to prevent bacterial sexually transmitted infections in the USA: final results from the DoxyPEP multicentre, open-label, randomised controlled trial and open-label extension.

Journal: The Lancet. Infectious diseases

Published: December 29, 2024

Showing 1-12 of 100

Last Updated: 09/26/2026